# abrdn Life Sciences Investors: Form DEF 14A, filed Apr 18, 2018

- Company: [abrdn Life Sciences Investors](/companies/hql.md) (CIK 884121)
- Form: DEF 14A
- Filed: 2018-04-18
- Accepted by EDGAR: Apr 18, 2018, 17:55 ET
- Period: 2018-06-14
- Accession: 0001104659-18-024806
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/884121/000110465918024806/a18-7715_3def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/884121/000110465918024806/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/884121/000110465918024806/a18-7715_3def14a.htm

Filed Apr 18, 2018.
Source: SEC EDGAR, the filing index for accession 0001104659-18-024806. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.